Top 5 Low Price Stocks To Invest In Right Now

Following past boom/bust cycles, the oil business appears to have bottomed in February 2016 at $27 a barrel. The bruising multi-year bust in crude oil prices was the biggest reason for the world stock market sell-off from late 2015 to early 2016 of roughly 15% overall. The cruel irony of ultra-low prices is its disruptive effect on regular exploration activity. A short-term oil market depression in expectations disproportionately slashes oil drilling activity. Oil exploration budgets for 2017 are down 65% from 2014 and the smallest in 12 years, DESPITE a record estimate for global demand next year. In the long-run, oil & gas development and production may fail to keep pace with the steady growth in total demand. Will the 2015-16 “bust” sow the seeds of the next “boom” phase in pricing?

Click to enlarge

Top 5 Low Price Stocks To Invest In Right Now: Stepan Company(SCL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Stepan Company (NYSE: SCL) were down 14 percent to $76.53 as the company posted downbeat Q1 results.

    Epizyme, Inc. (NASDAQ: EPZM) was down, falling around 14 percent to $13.125. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.

  • [By Stephan Byrd]

    Several research analysts have weighed in on SCL shares. Zacks Investment Research raised Stepan from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a research report on Tuesday, January 1st. ValuEngine raised Stepan from a “hold” rating to a “buy” rating in a research report on Monday, February 4th. Stifel Nicolaus started coverage on Stepan in a research report on Monday, December 10th. They issued a “buy” rating and a $94.00 price objective on the stock. Finally, Seaport Global Securities reissued a “hold” rating and issued a $95.00 price objective on shares of Stepan in a research report on Monday, November 5th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $74.50.

    TRADEMARK VIOLATION NOTICE: “Eagle Asset Management Inc. Sells 3,038 Shares of Stepan (SCL)” was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at www.tickerreport.com/banking-finance/4195550/eagle-asset-management-inc-sells-3038-shares-of-stepan-scl.html.

    Stepan Company Profile

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to

Top 5 Low Price Stocks To Invest In Right Now: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    However, VivoPower and our other penny stocks to watch this week already saw big gains. After looking at our 10 top penny stocks to watch, we’ll show you a small-cap stock with serious profit potential in its future…

    Penny Stock Current Share Price Law Week’s Gain
    VivoPower International Plc. (Nasdaq: VVPR) $3.05 88.57%
    Euro Tech Holdings Co. (Nasdaq: CLWT) $3.77 75.11%
    Boxlight Corp. (Nasdaq: BOXL) $6.36 65.38%
    Chine Recycling Energy Corp. (Nasdaq: CREG) $2.01 45.92%
    Vivis Inc. (Nasdaq: VVUS) $0.52 38.82%
    HC2 Holdings Inc. (NYSE: HCHC) $6.79 33.49%
    Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) $2.67 32.23%
    Turtle Beach Corp. (Nasdaq: HEAR) $6.99 30.19%
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $3.30 29.24%
    Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 29.19%

    While the gains of last week’s top penny stocks are exciting, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
     Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Media stories about VIVUS (NASDAQ:VVUS) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VIVUS earned a news impact score of 0.13 on Accern’s scale. Accern also gave press coverage about the biopharmaceutical company an impact score of 47.022479468622 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 5 Low Price Stocks To Invest In Right Now: John Bean Technologies Corporation(JBT)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    John Bean Technologies Corp  (NYSE:JBT)Q4 2018 Earnings Conference CallFeb. 26, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on John Bean Technologies (JBT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    John Bean Technologies (NYSE:JBT) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. JPMorgan Chase & Co. currently has $88.00 price target on the stock.

  • [By Max Byerly]

    John Bean Technologies Corp (NYSE:JBT) has been given a consensus recommendation of “Hold” by the ten ratings firms that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $92.33.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on John Bean Technologies (JBT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Invest In Right Now: Xylem Inc.(XYL)

Advisors’ Opinion:

  • [By Max Byerly]

    Hsbc Holdings PLC cut its holdings in Xylem Inc. (NYSE:XYL) by 7.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 309,799 shares of the industrial products company’s stock after selling 26,335 shares during the quarter. Hsbc Holdings PLC’s holdings in Xylem were worth $23,830,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Xylem Inc (NYSE:XYL) has been assigned an average rating of “Buy” from the fifteen ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $78.31.

  • [By John Rotonti]

    On the other hand, the right investments in R&D efforts to develop new products and services can help companies differentiate themselves from competitors and build sustainable moats. Xylem (NYSE:XYL), a leading pure-play water technology provider, has increased its R&D investments as a percentage of sales to accelerate the pace of innovation across its product portfolio. 3M (NYSE:MMM), with its diversified product portfolio and strong focus on innovation, is another example.

  • [By Joseph Griffin]

    Xylem Inc (NYSE:XYL) has been assigned an average recommendation of “Buy” from the twelve brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $79.78.

Top 5 Low Price Stocks To Invest In Right Now: HomeTrust Bancshares, Inc.(HTBI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Hometrust Bancshares (NASDAQ:HTBI) and Dime Community Bancshares (NASDAQ:DCOM) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

  • [By Joseph Griffin]

    Hometrust Bancshares (NASDAQ: HTBI) and TFS Financial (NASDAQ:TFSL) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

  • [By Shane Hupp]

    Hometrust Bancshares (NASDAQ:HTBI) was downgraded by equities researchers at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Wednesday.

  • [By Shane Hupp]

    Headlines about Hometrust Bancshares (NASDAQ:HTBI) have trended somewhat positive on Saturday, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Hometrust Bancshares earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 46.8198551712188 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Joseph Griffin]

    Northrim BanCorp (NASDAQ: NRIM) and Hometrust Bancshares (NASDAQ:HTBI) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Leave a Reply

Your email address will not be published. Required fields are marked *